Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR ‐γ selective topical retinoid, in patients with moderate facial and truncal acne-Reference-Cited by-同舟云学术

Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR ‐γ selective topical retinoid, in patients with moderate facial and truncal acne

Published:2019-08-20 Issue:1 Volume:34 Page:166-173
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Blume‐Peytavi U.¹,Fowler J.²,Kemény L.³,Draelos Z.⁴,Cook‐Bolden F.⁵,Dirschka T.⁶,Eichenfield L.⁷,Graeber M.⁸,Ahmad F.⁸,Alió Saenz A.⁸,Rich P.⁹,Tanghetti E.¹⁰

Affiliation:

1. Department of Dermatology and Allergy Charité‐Universitätsmedizin Berlin Berlin Germany

2. Division of Dermatology University of Louisville Louisville KY USA

3. Department of Dermatology and Allergy University of Szeged Szeged Hungary

4. Dermatology Consulting Services PLLC High Point NC USA

5. Skin Specialty Dermatology New York NY USA

6. Centroderm Clinic Wuppertal Germany

7. Departments of Dermatology and Pediatrics University of California San Diego School of Medicine and Rady Children's Hospital San Diego CA USA

8. Galderma Research and Development LLC Fort Worth TX USA

9. Oregon Dermatology and Research Portland OR USA

10. Center for Dermatology and Laser Surgery Sacramento CA USA

Publisher